| Literature DB >> 24180224 |
Qi Zhang, Yu-Xuan Lu, Wei-Hua Xu1.
Abstract
BACKGROUND: Diapause is programmed developmental arrest coupled with the depression of metabolic activity and the enhancement of stress resistance. Pupal diapause is induced by environmental signals and is prepared during the prediapause phase. In the cotton bollworm, Helicoverpa armigera, the prediapause phase, which contains two sub-phases, diapause induction and preparation, occurs in the larval stage. Here, we performed parallel proteomic and metabolomic analyses on H. armigera larval hemolymph during the prediapause phase.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24180224 PMCID: PMC4046812 DOI: 10.1186/1471-2164-14-751
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Figure 1Representative 2-DE images of the proteins from larval hemolymph. Proteins were extracted from nondiapause- (N) and diapause-destined (D) larval hemolymph at four stages: (A and B) mid-late stage of the fifth instar, (C and D) early stage of the sixth instar, (E and F) middle stage of the sixth instar, and (G and H) late stage of the sixth instar. Proteins were separated by IEF (18 cm IPG strips, pH 4–7, L) and 12% SDS-PAGE. Gels were stained by MS-compatible silver stain. Based on triplicate replications, only statistically significant (p-value < 0.05) protein spots that changed ≥1.5-fold were considered for further analysis. Differentially expressed protein spots are marked with letters and numbers. Letters 'a’, 'b’, 'c’, and 'd’ represent the mid-late stage of the fifth instar, the early, the middle, and the late stages of the sixth instar, respectively.
Figure 2Number of differentially expressed proteins (A) and classification of the identified proteins (B) in larval hemolymph in the prediapause phase.
Differentially expressed proteins identified by MALDI-TOF/TOF
| Spot no. | Protein name | Organism | NCBI accession no. | Theoretical MW(kDa)/pl | Fold change | Database | Mowse scorea | No. of peptides | EC no. |
|---|---|---|---|---|---|---|---|---|---|
| Proteins increased in diapause larval hemolymph | |||||||||
| a1 | Serpin 3a |
| gi|27733415 | 51.13/5.26 | 2.8 | EST_Har | 311 | 4 | - |
| a5 | Ommochrome binding protein |
| gi|400673 | 30.61/5.89 | 1.5 | EST_Har | 369 | 4 | - |
| b6 | Glutathione S-transferase |
| gi|297340786 | 23.72/6.18 | 2.8 | EST_Har | 202 | 3 | EC:2.5.1.18 |
| b7 | Hydroxypyruvate isomerase |
| gi|357604475 | 29.12/6.00 | specific | EST_others | 151 | 2 | EC: 5.3.1.22 |
| b8 | Pyridoxine 5′-phosphate oxidase |
| gi|112984194 | 29.87/8.76 | 1.5 | EST_Har | 120 | 2 | EC:1.4.3.5 |
| c5 | C-type lectin 7 |
| gi|385202653 | 34.99/5.98 | 2.3 | EST_Har | 116 | 2 | - |
| c7 | Serpin |
| gi|314912147 | 43.53/5.04 | 2.7 | EST_Har | 92 | 2 | - |
| c9 | Imaginal disc growth factor-like protein |
| gi|85726208 | 47.83/7.08 | 3.8 | NCBI | 99 | 1b | EC:3.2.1.14 |
| d4 | Beta-1,3-glucan recognition protein 3 |
| gi|208972535 | 53.37/5.85 | 1.9 | NCBI | 262 | 4 | EC:3.2.1- |
| d5 | Putative serine protease-like protein 2 |
| gi|56462300 | 32.15/5.79 | 5.9 | EST_others | 182 | 2 | EC:3.4.21.- |
| d6 | C-type lectin 7 |
| gi|385202653 | 34.99/5.98 | 7.4 | EST_Har | 128 | 2 | - |
| d7 | C-type lectin 7 |
| gi|385202653 | 34.99/5.98 | 5.5 | EST_Har | 102 | 2 | - |
| d8 | Serpin |
| gi|314912147 | 43.53/5.04 | 2.9 | EST_Har | 165 | 2 | - |
| d11 | Ferritin |
| gi|7272336 | 26.51/5.44 | 2.6 | EST_Har | 193 | 3 | - |
|
| |||||||||
| a2 | Growth-blocking peptide binding protein |
| gi|238915973 | 23.63/5.16 | 1.7 | EST_others | 79 | 1 | - |
| a3 | Sulfatase |
| gi|357631807 | 56.65/5.34 | 2.2 | EST_others | 105 | 1 | EC:3.1.6.14 |
| a4 | Sulfatase |
| gi|357631807 | 56.65/5.34 | 2.3 | EST_others | 114 | 1 | EC:3.1.6.14 |
| a6 | EndoU protein, partial |
| gi|389615052 | 28.70/8.38 | 3.3 | EST_Har | 217 | 4 | EC:3.1-- |
| a7 | Kazal-type inhibotor |
| gi|357625979 | 22.97/5.07 | 1.8 | EST-Har | 229 | 2 | - |
| b1 | Protein disulfide isomerase |
| gi|112984454 | 55.59/4.60 | 5.7 | EST_others | 140 | 2 | EC:5.3.4.1 |
| b3 | Ommochrome-binding protein |
| gi|400673 | 30.61/5.89 | 2.8 | EST_Har | 207 | 3 | - |
| b5 | Hemolymph proteinase 18 |
| gi|56418417 | 44.14/5.94 | 2.0 | EST_Har | 49 | 1 | EC:3.4.21- |
| c2 | Serine proteinase-like protein 1 |
| gi|208972549 | 46.51/5.43 | 1.8 | NCBI | 129 | 3 | EC:3.4.21- |
| c3 | C-type lectin |
| gi|106897087 | 38.01/5.42 | 1.9 | EST_Har | 49 | 1 | - |
| c4 | C-type lectin |
| gi|106897087 | 38.01/5.42 | 2.9 | EST_Har | 118 | 1 | - |
| d1 | Serine proteinase-like protein 1 |
| gi|208972549 | 46.51/5.43 | 10.7 | NCBI | 84 | 2 | EC:3.4.21- |
| d2 | Serine proteinase-like protein 1 |
| gi|208972549 | 46.51/5.43 | 10.7 | NCBI | 148 | 3 | EC:3.4.21- |
| d12 | Unknown secreted protein |
| gi|389609461 | 17.50/8.55 | 2.3 | EST_Har | 195 | 3 | EC:3.4.21 |
aMowse scores greater than the significance threshold indicate identity or extensive homology (p < 0.05). Three database have their respective significance thresholds, the EST_Har database is 31, the NCBInr database is 46, and the NCBI EST_others database is 57.bAdditional data for single peptide-based identifications are presented in Additional file 2: Figure S2.
Metabolites identified in tha larval hemolymph from
| Metabolite | Fold change of relative ratioa | |||
|---|---|---|---|---|
| Mid-late 5th | Early 6th | Mid 6th | Late 6th | |
|
| ||||
| Alanine | nsb | ns | ns | ns |
| β-Alanine | ns | ns | ns | ns |
| Glutamate | ns | ns | ns | ns |
| Glycine | ns | ns |
| ns |
| Histidine | ns |
| -c | - |
| Homoserine | ns | ns | - | - |
| Isoleucine | ns | ns | ns | ns |
| Leucine | ns | ns | ns | ns |
| Methionine | ns | ns | ns | ns |
|
| ns | ns | - |
|
| Ornithine | ns | ns |
| ns |
| Phenylalanine | ns | ns | ns | ns |
| Proline | ns | ns | ns | ns |
| Serine | ns | ns | ns | ns |
| Threonine | ns | ns | ns | ns |
| Tryptophan | - | - | - | ns |
| Tyrosine | ns | ns | ns | ns |
| Valine | ns | ns | ns | ns |
|
| ||||
| Arabinitol | ns | ns | - | - |
| Cholesterol | ns | ns | ns | ns |
| Erythritol | ns | ns | - | - |
| Fructose | ns | ns |
| ns |
| Galactitol | ns | ns | - | - |
| Glucose | ns |
|
|
|
| Glycerol | ns | ns |
| ns |
| Myo-inositol | ns | ns | ns | ns |
| Ribitol | ns | ns |
| - |
| Sitosterol | ns | ns | ns | ns |
| Trehalose | ns |
| ns | ns |
| Turanose | - | ns | ns | ns |
|
| ||||
| Fumaric acid | ns | ns | ns | ns |
| Isocitric acid | ns | ns | ns | ns |
| Malic acid | ns | ns | ns | ns |
| Pyruvate | ns | ns |
| ns |
| Succinic acid | ns | ns | ns | ns |
| Urea | ns | ns |
| - |
|
| ||||
| Free amine | ns | ns | ns | ns |
| Free phosphate | ns | ns | ns | ns |
| Phosphoric acid | ns | ns |
| ns |
|
| ||||
| 2-Hydroxymandelic acid | - | - | ns | ns |
| 3-Aminoisobutyric acid | ns | ns | ns | ns |
| 3-Hydroxy-3-methylglutaric acid | - | - |
| ns |
| 3-Hydroxypropanoic acid | ns | ns | - | - |
| ns | ns | ns | ns | |
| Galatonic acid | ns | ns | - | - |
| γ-Aminobutyric acid | ns | ns |
| ns |
| Gluconic acid | ns | ns | ns |
|
| Glyceric acid | - | ns | - | - |
| Linoleic acid | - | ns | - | - |
| Methylcitric acid | - | ns | ns | ns |
| Mevalonic acid | ns |
| - | ns |
|
| ns | ns | - |
|
| Octadecenoic | - | - | ns | ns |
| Palmitic acid | ns | ns | ns | ns |
| Pantothenic acid | ns | - | ns | ns |
| Phosphorylethanolamine |
| ns |
| ns |
| Ribonic acid | ns | ns |
| ns |
| Stearic acid | - | - | ns | ns |
| Threonic acid | ns | ns | - | - |
a Fold change with a positive number indicates metabolic levels were significantly increased in diapause-destine larval hemolymph, while a negative number indicates metabolite levels were significantly decreased in destined diapause-destine larval hemolymph. Based on four biological replicate analyses, only metabolites that changes ≥1.5-fold in relative ratios (p-value < 0.05) were considered for further analysis, and were marked in bold. b ns, no significant difference. c-, metabolite was found in less than three measurements and wasn’t able to be quantified accurately. d Metabolite was only found in dispause-destined larval hemolymph.
Figure 3Number (A) and classification (B) of significantly changed metabolites in larval hemolymph in the prediapause phase.
Figure 4Principal component analysis score plots of the hemolymph metabolites by comparison of nondiapause- (circle) and diapause-destined (cross) larvae in the prediapause phase at four stages: (A) mid-late stage of the fifth instar, (B) early stage of the sixth instar, (C) middle stage of the sixth instar, and (D) late stage of the sixth instar.